Anju ClinPlus, LLC
Anju ClinPlus, LLC

Anju ClinPlus, LLC Information

Contact top employees from Anju ClinPlus, LLC

Summary

Anju ClinPlus, LLC is a private company that has been in the industry for 29 years. The company currently specializes in the Pharmaceuticals area. The position of the President & CEO is occupied by Doron Z. Steger. Its headquarters is located at Tempe, Arizona, USA. The number of employees ranges from 25 to 100. The annual revenue of Anju ClinPlus, LLC varies between 5.0M and 25M. To connect with Anju ClinPlus, LLC employee register on SignalHire.

Industries

Pharmaceuticals

Headquarters Location

Employees Size

10-50 employees

Specialties

Clinical Trial Software, Data Management, Medical Coding, Report TFLs

SIC Code

7372, 7370

DMA Code

Phoenix Metropolitan Area

Founded

1996

Estimated Annual Revenue

$5.0M - 25M

Operating Status

Subsidiary

Contact Anju ClinPlus, LLC

Organization Website

Phone Number

+ 1 732.764.6969

Competitors

Founded
Type
Employees
Revenue
Funding
1888Public
Company
100K - 9.9M 40.2B $6.9M
1935Public
Company
10K - 50K 2.6B $0
1858Public
Company
10K - 50K 44.4B $0
2014- 200-500 - $-

Employees Turnover 3 quarter 2025

Length of Employment
arrow
Employee tenure at Anju ClinPlus, LLC shows a diverse range of experience levels:
100% have over 11 years of service at Anju ClinPlus, LLC
Contact top employees from Anju ClinPlus, LLC
Bob Borysko
Solutions Engineer
View
Ben Coopersmith
Systems and Integrations Specialist
View

FAQ

Anju ClinPlus, LLC operates in the Pharmaceuticals industries. More details can be found on the official website: clinplus.com.
The headquarters of Anju ClinPlus, LLC are located in Bound Brook, United States.
The current CEO of Anju ClinPlus, LLC is Doron Z. Steger
You can contact Anju ClinPlus, LLC by phone at + 1 732.764.6969.
Anju ClinPlus, LLC currently employs 10-50 people.
Anju ClinPlus, LLC's revenue is approximately 13.7M.
Well-known competitors of Anju ClinPlus, LLC include Abbott, Cipla, Bristol Myers Squibb and AltMed Enterprises.
BACK TO TOP